Phase II Study of Sorafenib + Carboplatin and Docetaxel in First Line Treatment of Stage IIIB/IV NSCLC
Clinical trial NCT00647426 · COMPLETED
Trial details
- NCT number
- NCT00647426
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Primary completion
- 2011-08-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.